{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:12:06Z","timestamp":1790075526402,"version":"4.0.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2010,7,29]],"date-time":"2010-07-29T00:00:00Z","timestamp":1280361600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s00384-010-1026-2","type":"journal-article","created":{"date-parts":[[2010,7,28]],"date-time":"2010-07-28T11:09:32Z","timestamp":1280315372000},"page":"1159-1165","source":"Crossref","is-referenced-by-count":42,"title":["Effectiveness of budesonide-succinate-dextran conjugate as a novel prodrug of budesonide against acetic acid-induced colitis in rats"],"prefix":"10.1007","volume":"25","author":[{"given":"Jaleh","family":"Varshosaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaber","family":"Emami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Fassihi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naser","family":"Tavakoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Minaiyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvin","family":"Mahzouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid","family":"Dorkoosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,7,29]]},"reference":[{"key":"1026_CR1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0378-5173(02)00344-7","volume":"245","author":"N Shimono","year":"2002","unstructured":"Shimono N, Takatori T, Ueda M, Mori M, Higashi Y, Nakamura Y (2002) Chitosan dispersed system for colon-specific drug delivery. Int J Pharm 245:45\u201354","journal-title":"Int J Pharm"},{"key":"1026_CR2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0378-5173(02)00112-6","volume":"239","author":"H Zhang","year":"2002","unstructured":"Zhang H, Alsarra IA, Neau SH (2002) An in vitro evaluation of a chitosan-containing multiparticulate system for macromolecule delivery to the colon. Int J Pharm 239:197\u2013205","journal-title":"Int J Pharm"},{"key":"1026_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(02)00004-2","volume":"235","author":"L Yang","year":"2002","unstructured":"Yang L, Chu JS, Fix JA (2002) Colon-specific drug delivery: new approaches and in vitro\/in vivo evaluation. Int J Pharm 235:1\u201315","journal-title":"Int J Pharm"},{"key":"1026_CR4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1098-3597(02)90005-0","volume":"4","author":"KL Knigge","year":"2002","unstructured":"Knigge KL (2002) Inflammatory bowel disease. Clin Cornerstone 4:49\u201357","journal-title":"Clin Cornerstone"},{"key":"1026_CR5","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1046\/j.1365-2036.2003.01426.x","volume":"17","author":"S Edsbacker","year":"2003","unstructured":"Edsbacker S, Bengtsson B, Larsson P, Lundin P, Nilsson A, Ulmius J, Wollmer P (2003) A pharmacoscintigraphic evaluation of oral budesonide given as controlled-release (Entocort) capsules. Aliment Pharmacol Ther 17:525\u2013536","journal-title":"Aliment Pharmacol Ther"},{"key":"1026_CR6","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.addr.2004.08.009","volume":"57","author":"RN Fedorak","year":"2005","unstructured":"Fedorak RN, Bistritz L (2005) Targeted delivery, safety, and efficacy of oral enteric-coated formulations of budesonide. Adv Drug Deliv Rev 57:303\u2013316","journal-title":"Adv Drug Deliv Rev"},{"key":"1026_CR7","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1046\/j.1365-2036.1998.00348.x","volume":"12","author":"DR Friend","year":"1998","unstructured":"Friend DR (1998) Issues in oral administration of locally acting glucocorticosteroids for treatment of inflammatory bowel disease. Aliment Pharmacol Ther 12:591\u2013603","journal-title":"Aliment Pharmacol Ther"},{"key":"1026_CR8","first-page":"439","volume":"35","author":"N Cui","year":"1994","unstructured":"Cui N, Friend DR, Fedorak RN (1994) A budesonide prodrug accelerates treatment of colitis in rats. Gut 35:439\u20131446","journal-title":"Gut"},{"key":"1026_CR9","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ejpb.2007.06.007","volume":"68","author":"MS Crcarevska","year":"2008","unstructured":"Crcarevska MS, Dodov MG, Goracinova K (2008) Chitosan coated Ca-alginate microparticles loaded with budesonide for delivery to the inflamed colonic mucosa. Eur J Pharm Biopharm 68:565\u2013578","journal-title":"Eur J Pharm Biopharm"},{"key":"1026_CR10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2125.2005.02517.x","volume":"61","author":"M Brunner","year":"2006","unstructured":"Brunner M, Ziegler S, Di Stefano AFD, Dehghanyar P, Kletter K, Tschurlovits M, Villa R, Bozzella R, Celasco G, Moro L, Rusca A, Dudczak R, Muller M (2006) Gastrointestinal transit, release and plasma pharmacokinetics of a new oral budesonide formulation. Br J Clin Pharmacol 61:31\u201338","journal-title":"Br J Clin Pharmacol"},{"key":"1026_CR11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijpharm.2008.08.034","volume":"365","author":"J Varshosaz","year":"2009","unstructured":"Varshosaz J, Emami J, Tavakoli N, Fassihi A, Minaiyan M, Ahmadi F, Dorkoosh F (2009) Synthesis and evaluation of dextran-budesonide conjugates as colon specific prodrugs for treatment of ulcerative colitis. Int J Pharm 365:69\u201376","journal-title":"Int J Pharm"},{"key":"1026_CR12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jep.2004.03.028","volume":"93","author":"LAF Paiva","year":"2004","unstructured":"Paiva LAF, Gurgel LA, De Sousa ET, Silveira ER, Silva RM, Santos FA, Rao VSN (2004) Protective effect of Copaifera langsdorffii oleo-resin against acetic acid-induced colitis in rats. J Ethnopharmacol 93:51\u201356","journal-title":"J Ethnopharmacol"},{"key":"1026_CR13","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/BF02877715","volume":"24","author":"A Aslan","year":"2007","unstructured":"Aslan A, Temiz M, Atik E, Polat G, Sahinler N, Besirov E, Aban N, Parsak C (2007) Effectiveness of mesalamine and propolis in experimental colitis. Adv Ther 24:1085\u20131097","journal-title":"Adv Ther"},{"key":"1026_CR14","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s10620-006-3159-2","volume":"51","author":"S Gorgulu","year":"2006","unstructured":"Gorgulu S, Yagci G, Kaymakcioglu N, Ozkara M, Kurt B, Ozcan A, Kaya O, Sadir S, Tufan T (2006) Hyperbaric oxygen enhances the efficiency of 5-aminosalicylic acid in acetic acid-induced colitis in rats. Dig Dis Sci 51:480\u2013487","journal-title":"Dig Dis Sci"},{"key":"1026_CR15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ejphar.2004.11.036","volume":"507","author":"A El Medany","year":"2005","unstructured":"El Medany A, Mahgoub A, Mustafa A, Arafa M, Morsi M (2005) The effects of selective cyclooxygenase-2 inhibitors, celecoxib and rofecoxib, on experimental colitis induced by acetic acid in rats. Eur J Pharmacol 507:291\u2013299","journal-title":"Eur J Pharmacol"},{"key":"1026_CR16","first-page":"238","volume":"69","author":"HS Cooper","year":"1993","unstructured":"Cooper HS, Murthy SN, Shah RS, Sedergran DJ (1993) Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 69:238\u2013249","journal-title":"Lab Invest"},{"key":"1026_CR17","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1053\/gast.2001.22470","volume":"120","author":"KL Williams","year":"2001","unstructured":"Williams KL, Randall Fuller C, Dieleman LA, DaCosta CM, Haldeman KM, Balfour Sartor R, Kay Lund P (2001) Enhanced survival and mucosal repair after dextran sodium sulfate-induced colitis in transgenic mice that overexpress growth hormone. Gastroenterology 120:925\u2013937","journal-title":"Gastroenterology"},{"key":"1026_CR18","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1365-2249.1998.00728.x","volume":"114","author":"LA Dieleman","year":"1998","unstructured":"Dieleman LA, Palmen MJHJ, Akol H, Bloemena E, Pena AS, Meuwissen SGM, Van Rees EP (1998) Chronic experimental colitis induced by dextran sulfate sodium (DSS) is characterized by Th1 and Th2 Cytokines. Clin Exp Immunol 114:385\u2013391","journal-title":"Clin Exp Immunol"},{"key":"1026_CR19","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s11894-007-0068-2","volume":"9","author":"A Swaminath","year":"2007","unstructured":"Swaminath A, Kornbluth A (2007) Optimizing drug therapy in inflammatory bowel disease. Curr Gastroenterol Rep 9:513\u2013520","journal-title":"Curr Gastroenterol Rep"},{"key":"1026_CR20","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1111\/j.1572-0241.1999.01222.x","volume":"94","author":"A Tromm","year":"1999","unstructured":"Tromm A, Griga T, Mollmann HW, May B, Muller KM, Fisseler-Eckhoff A (1999) Budesonide for the treatment of collagenous colitis: first results of a pilot trial. Am J Gastroenterol 94:1871\u20131875","journal-title":"Am J Gastroenterol"},{"key":"1026_CR21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.biopha.2008.02.002","volume":"62","author":"ZH Ran","year":"2008","unstructured":"Ran ZH, Chen C, Xiao SD (2008) Epigallocatechin-3-gallate ameliorates rats colitis induced by acetic acid. Biomed Pharmacother 62:189\u2013196","journal-title":"Biomed Pharmacother"},{"key":"1026_CR22","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1211\/0022357011776658","volume":"53","author":"M Rodriguez","year":"2001","unstructured":"Rodriguez M, Antunez JA, Taboada C, Seijo B, Torres D (2001) Colon-specific delivery of budesonide from microencapsulated cellulosic cores: evaluation of the efficacy against colonic inflammation in rats. J Pharm Pharmacol 53:1207\u20131215","journal-title":"J Pharm Pharmacol"},{"key":"1026_CR23","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1211\/0022357991772420","volume":"51","author":"H Tozaki","year":"1999","unstructured":"Tozaki H, Fujita T, Komoike J, Kim SI, Terashima H, Muranishi S, Okabe S, Yamamoto A (1999) Colon-specific delivery of budesonide with azopolymer-coated pellets: therapeutic effects of budesonide with a novel dosage form against 2, 4, 6-trinitrobenzenesulphonic acid-induced colitis in rats. J Pharm Pharmacol 51:257\u2013261","journal-title":"J Pharm Pharmacol"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-010-1026-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00384-010-1026-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-010-1026-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T16:05:32Z","timestamp":1559059532000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00384-010-1026-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,29]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["1026"],"URL":"https:\/\/doi.org\/10.1007\/s00384-010-1026-2","relation":{},"ISSN":["0179-1958","1432-1262"],"issn-type":[{"value":"0179-1958","type":"print"},{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,29]]}}}